A Beginners Guide to Network Meta Analysis - Dr Chris Noone

Network meta-analysis is positioned as a decision-making tool that can answer not only whether interventions work, but which specific option works best—by combining direct head-to-head trial evidence with indirect comparisons across a whole “network” of treatments. In psychology and other health fields where trials often compare different therapies against different control conditions, traditional pairwise meta-analysis tends to lump heterogeneous interventions together, inflating uncertainty and obscuring practical choices. Network meta-analysis instead keeps interventions and control groups distinct, estimates effects across many pairings, and can infer comparisons that never appeared in a single trial.

The talk starts with the limits of pairwise meta-analysis for complex behavioral interventions. When social anxiety treatments include multiple therapy types (e.g., cognitive behavioral therapy, cognitive therapy, social skills training) and trials use varied control groups, combining them into one “psychological intervention” effect breaks the assumption that trials share a common effect. Similarly, control groups produce different effect sizes, which increases heterogeneity and makes interpretation less useful for clinicians and policymakers. Pairwise meta-analysis can indicate whether treatments generally outperform controls, and sometimes compare two interventions directly when enough head-to-head trials exist—but it cannot reliably identify the best option among many alternatives.

Network meta-analysis addresses these gaps by building a network where each treatment (and often each control) is a node, and the thickness of connections reflects how many trials compare those nodes directly. With this structure, analysts can compute direct effects from head-to-head studies, derive indirect effects when two treatments share a common comparator, and then integrate both sources into a single network estimate. The method also supports ranking interventions using multiple ranking approaches, producing a practical output for funding and guideline decisions.

Key validity assumptions receive special attention. Homogeneity in network meta-analysis is reframed through transitivity and consistency: transitivity requires that effect modifiers are similarly distributed across comparisons (for example, participant characteristics or delivery contexts should not systematically differ between parts of the network), while consistency checks whether indirect and direct evidence agree for the same comparison. Disconnected networks are another practical risk: if some interventions are only compared within a subgraph that never links back to the rest (often through a shared control), the network becomes harder to analyze and may require complex handling.

Because many health interventions are “complex,” the talk emphasizes additional considerations. Control conditions such as “usual care” may not be truly comparable across trials, and bias in complex interventions can propagate through the network, affecting estimates beyond where it originates. The ideal scenario includes both direct and indirect evidence, reliable and consistent outcome measurement (often supported by standard outcome sets), transparent reporting, and—where possible—individual participant data sharing.

To deal with complexity, the presentation highlights component-based network meta-analysis. Instead of treating each intervention as a single package, interventions can be decomposed into clinically meaningful components (or dismantled into essential techniques), coded using behavior change technique frameworks and related taxonomies, and then modeled so that component combinations become nodes. This approach can identify which components are effective and which appear inert, including potential interactions between components.

Finally, a step-by-step workflow is illustrated using a hypertension example comparing physical activity interventions with first-line anti-hypertensive pharmacological therapies. The process adapts systematic review planning via a PRISMA extension for network meta-analysis, broadens the intervention/comparator criteria, screens and selects studies to build a connected network, checks consistency, and reports both pairwise results and network estimates (including ranking outputs). The session closes with resources and training options, plus a forward look at methodological development—especially automation for component extraction and AI-assisted evidence updating—alongside the continued need for statistical expertise, even if user-friendly tools can support teaching and learning.